Lead sponsor
Memorial Sloan Kettering Cancer Center
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
1
Trials led
1
Active
36
Total enrollment
7
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Early Phase 1
1
Trials by status
Recruiting
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
A Study of a Weight Loss Intervention in People With Endometrial CancerBMI ≥30Early Ph 1Recruiting36